Technical Analysis for SIBN - SI-BONE, Inc.

Grade Last Price % Change Price Change
F 15.95 -0.56% -0.09
SIBN closed down 0.56 percent on Monday, March 18, 2024, on 1.44 times normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions. Due to the stock's strong downtrend, it may remain oversold for a while. So, if you're looking for a reason to buy, don't put too much weight on it being oversold.
0 Watchers
Watchlist Portfolio

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Strong Down Down Down

Date Alert Name Type % Chg
NR7 Range Contraction 0.00%
Narrow Range Bar Range Contraction 0.00%
Inside Day Range Contraction 0.00%
Wide Bands Range Expansion 0.00%
Down 3 Days in a Row Weakness 0.00%
Down 4 Days in a Row Weakness 0.00%
Down 5 Days in a Row Weakness 0.00%
Oversold Stochastic Weakness 0.00%
Doji - Bullish? Reversal -0.56%
Wide Bands Range Expansion -0.56%

   Recent Intraday Alerts

Alert Time
Possible NR7 about 15 hours ago
Possible Inside Day about 15 hours ago
Down 1% about 19 hours ago
60 Minute Opening Range Breakdown 4 days ago
Down 3% 4 days ago

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

SI-BONE, Inc. Description

SI-BONE is a medical device company that pioneered the iFuse Implant System, a minimally invasive surgical system for fusion of the sacroiliac joint to treat sacroiliac joint dysfunction. The SI joint is believed to be the last major joint with a clinically proven surgical treatment. The iFuse Implant, commercially available since 2009, is believed to be the only SI joint fusion device supported by multiple prospective clinical studies showing improved pain, patient function and quality of life resulting from treatment. There are over 60 peer-reviewed publications supporting the safety, effectiveness, and biomechanical and economic benefits unique to the iFuse Implant. This body of evidence has enabled multiple government and private payors to establish coverage of the SI joint fusion procedure exclusively when performed with the iFuse Implant System.


Classification

Sector: Healthcare
Industry: Medical Devices
Keywords: Medicine Surgery Bone Dysfunction Prosthetics Implant Quality Of Life Minimally Invasive Procedure Pelvis Surgical Treatment Joint Dysfunction Medical Classification Sacroiliac Joint

Is SIBN a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 29.51
52 Week Low 15.57
Average Volume 464,430
200-Day Moving Average 21.15
50-Day Moving Average 19.22
20-Day Moving Average 17.96
10-Day Moving Average 16.97
Average True Range 0.75
RSI (14) 28.06
ADX 36.17
+DI 8.42
-DI 31.88
Chandelier Exit (Long, 3 ATRs) 18.95
Chandelier Exit (Short, 3 ATRs) 17.85
Upper Bollinger Bands 21.03
Lower Bollinger Band 14.88
Percent B (%b) 0.17
BandWidth 34.25
MACD Line -0.99
MACD Signal Line -0.80
MACD Histogram -0.1836
Fundamentals Value
Market Cap 645.99 Million
Num Shares 40.5 Million
EPS -1.18
Price-to-Earnings (P/E) Ratio -13.52
Price-to-Sales 6.47
Price-to-Book 4.91
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 16.40
Resistance 3 (R3) 16.38 16.20 16.33
Resistance 2 (R2) 16.20 16.09 16.22 16.30
Resistance 1 (R1) 16.08 16.02 15.99 16.10 16.27
Pivot Point 15.90 15.90 15.86 15.92 15.90
Support 1 (S1) 15.78 15.79 15.69 15.80 15.63
Support 2 (S2) 15.60 15.72 15.62 15.60
Support 3 (S3) 15.48 15.60 15.58
Support 4 (S4) 15.50